Returning guest, Brad Bostic, chairman, and CEO of hc1, the bioinformatics leader in precision testing and prescribing, discusses the collaboration between hc1 and Quest Diagnostics, the largest provider of lab testing in the U.S. He also talks about the current challenges health systems face in improving the quality and cost-efficiency of their lab management strategies, how a streamlined test utilization or lab stewardship program results in better patient care and overall health outcomes, and the impact a solid lab stewardship program will have on millions of patients.
Brad Bostic founded hc1 to improve lives with high-value care. More than 1,000 lab and health system locations use the hc1 platform to ensure tens of millions of patients each year get the right diagnostic lab tests and the right prescriptions, resulting in the best possible outcomes. Today, hc1 has grown to become the bioinformatics leader in precision testing and prescribing with many of the world’s most progressive health systems and laboratories leveraging its solutions to deliver scalable personalized medicine. Brad has been building and leading advanced cloud technology companies for more than two decades. A well-known innovator in the healthcare technology market, he has been named to the Becker’s Hospital Review list of Top Entrepreneurs in Healthcare and the Indianapolis Business Journal’s 40-Under-40 list of business leaders.